Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

CareDx to Participate in Upcoming Investor Conferences

businesswire.com
CDNA The article announces CareDx's participation in upcoming investor conferences. This is a standard corporate announcement and does not inherently convey positive or negative sentiment about the company's performance or prospects.

CareDx to Participate in Upcoming Investor Conferences BRISBANE, Calif.--( BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced the company will participate in the following investor conferences:

Fireside chat on Monday, June 8, 2026, at 1:20pm ET.

Live and archived webcasts of the presentations will be available on the “Events and Presentations” section of the CareDx investor relations website at investors.caredx.com.

About CareDx

CareDx is a precision medicine company dedicated to improving outcomes for transplant patients and advancing organ health. The Company’s integrated solutions include non‑invasive molecular testing for heart, kidney, and lung transplants; laboratory products; digital health technologies; and patient solutions that support care before and after transplant. CareDx is the leading provider of genomics‑based information for transplant patients. For more information, please visit www.caredx.com.